Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Syntaxin-1A is a membrane-anchored SNARE protein critical for synaptic vesicle exocytosis in neurons. It is predominantly found at the presynaptic active zone and facilitates the assembly of the core SNARE complex (with SNAP-25 and synaptobrevin/VAMP2), which drives fusion of neurotransmitter-containing vesicles with the plasma membrane. Syntaxin-1A cycles between ‘closed’ (inactive) and ‘open’ (fusion-competent) conformations, regulated by interacting proteins (e.g., Munc18-1). Its function is essential for rapid synaptic transmission, and its dysregulation is linked to neurological disorders. Toxins such as botulinum and tetanus block neurotransmitter release by proteolytically cleaving Syntaxin-1A or other SNARE proteins, illustrating its pivotal role in neuronal communication[1][2][3][5][8].
Inhibitors such as botulinum neurotoxin and tetanus toxin cleave SNARE proteins (including Syntaxin-1A), blocking SNARE complex assembly and inhibiting neurotransmitter release[5]
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Syntaxin-1A (STX1A).